Jose Manuel Monje Moreno-rekin lankidetzan egindako argitalpenak (8)
2024
-
Ribonucleotide reductase inhibition improves the symptoms of a Caenorhabditis elegans model of Alzheimer’s disease
G3: Genes, Genomes, Genetics, Vol. 14, Núm. 5
2023
-
Asparagus Fructans as Emerging Prebiotics
Foods, Vol. 12, Núm. 1
-
Europium doped-double sodium bismuth molybdate nanoparticles as contrast agents for luminescence bioimaging and X-ray computed tomography
Inorganic Chemistry Frontiers, Vol. 10, Núm. 11, pp. 3202-3212
2021
-
Steroid hormones sulfatase inactivation extends lifespan and ameliorates age-related diseases
Nature Communications, Vol. 12, Núm. 1
2020
-
Identification of bioactive compounds in diabetes and infertility models of C. elegans
Biosaia: Revista de los másteres de Biotecnología Sanitaria y Biotecnología Ambiental, Industrial y Alimentaria, Núm. 9
2019
-
Redox-dependent and redox-independent functions of Caenorhabditis elegans thioredoxin 1
Redox Biology, Vol. 24
2014
-
Developmental defects in a caenorhabditis elegans model for type III galactosemia
Genetics, Vol. 198, Núm. 4, pp. 1559-1569
2011
-
Pkc-1 regulates daf-2 insulin/IGF signalling-dependent control of dauer formation in Caenorhabditis elegans
Aging Cell, Vol. 10, Núm. 6, pp. 1021-1031